A Randomized, Placebo-Controlled Study of the Pharmacokinetics, Pharmacodynamics, and Tolerability of the Oral JAK2 Inhibitor Fedratinib (SAR302503)in Healthy Volunteers

作者:Zhang Meng*; Xu Christine R; Shamiyeh Elias; Liu Feng; Yin Jian Y; von Moltke Lisa L; Smith William B
来源:JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54(4): 415-421.
DOI:10.1002/jcph.218